Literature DB >> 35663721

Frontliners on the Move: A Quantitative Analysis of the Prevalence of COVID-19 Reinfection Among Healthcare Workers.

Nithin C Kurra1, Krithika Sriram2, Nikhila Gandrakota3, Jai Sivanandan Nagarajan4, Sujoy Khasnavis5, Manju Ramakrishnan6, Suhani Dalal7, Shayan A Irfan8, Sarah Khan9, Hariniska Jk10, Dhruv Patel11, Gayathri Samudrala12,13.   

Abstract

This study was conducted to review relevant articles and demonstrate the prevalence of coronavirus disease 2019 (COVID-19) reinfection among healthcare workers (HCWs). A systemic search was conducted on PubMed and Medline from their inception to July 17, 2021. All statistical analyses were conducted using ReviewManager 5.4.1. Studies meeting the following inclusion criteria were selected: (a) articles having HCWs with COVID-19; (b) studies describing reinfection of COVID-19; and (c) articles having a defined number of patients and controls. Three studies were selected for meta-analysis. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of the cohort studies. NOS scores of 1-5 were considered high risk for bias, scores of 6-7 were deemed moderate, and scores >7 were considered low risk for bias. A random-effect model was used when heterogeneity was seen to pool the studies, and the results were reported in inverse variance (IV) and corresponding 95% confidence interval (CI). Pooled prevalence of reinfection of COVID-19 in HCWs was 3% (OR: 0.03 [-0.04, 0.01]; p=0.44; I2 =4%). A non-significant prevalence was found among the healthcare professionals in terms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in Europe. The preformed antibodies were protective against reinfection. However, the waning of antibodies with respect to time was evident, varying differently in different individuals, thereby resulting in reinfection.
Copyright © 2022, Kurra et al.

Entities:  

Keywords:  covid-19; covid-19 in physicians; covid-19 infection; front line workers; healthcare workers; prevalence; reinfection; sars-cov-2 (severe acute respiratory syndrome coronavirus -2)

Year:  2022        PMID: 35663721      PMCID: PMC9155986          DOI: 10.7759/cureus.24652

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  38 in total

1.  Reinfection of COVID-19 in Pakistan: A First Case Report.

Authors:  Muhammad Hanif; Muhammad Adnan Haider; Mukarram Jamat Ali; Sidra Naz; Fnu Sundas
Journal:  Cureus       Date:  2020-10-26

Review 2.  COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment.

Authors:  Anant Parasher
Journal:  Postgrad Med J       Date:  2020-09-25       Impact factor: 2.401

Review 3.  COVID-19 is, in the end, an endothelial disease.

Authors:  Peter Libby; Thomas Lüscher
Journal:  Eur Heart J       Date:  2020-09-01       Impact factor: 29.983

4.  Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure.

Authors:  Adrián Sánchez-Montalvá; Candela Fernández-Naval; Andrés Antón; Xavier Durà; Alba Vimes; Aroa Silgado; Fernando Velásquez-Orozco; Juan Espinosa-Pereiro; Fernando Salvador; Tomás Pumarola; Benito Almirante; Juliana Esperalba
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241

5.  Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.

Authors:  Yang Pan; Luyao Long; Daitao Zhang; Tingting Yuan; Shujuan Cui; Peng Yang; Quanyi Wang; Simei Ren
Journal:  Clin Chem       Date:  2020-06-01       Impact factor: 8.327

6.  Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis.

Authors:  Mahalul Azam; Rina Sulistiana; Martha Ratnawati; Arulita Ika Fibriana; Udin Bahrudin; Dian Widyaningrum; Syed Mohamed Aljunid
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

7.  A systematic review of re-detectable positive virus nucleic acid among COVID-19 patients in recovery phase.

Authors:  Zhiru Gao; Yinghui Xu; Ye Guo; Dongsheng Xu; Li Zhang; Xu Wang; Chao Sun; Shi Qiu; Kewei Ma
Journal:  Infect Genet Evol       Date:  2020-08-05       Impact factor: 3.342

8.  Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study.

Authors:  Liting Chen; Gaoxiang Wang; Xiaolu Long; Hongyan Hou; Jia Wei; Yang Cao; Jiaqi Tan; Weiyong Liu; Liang Huang; Fankai Meng; Lifang Huang; Na Wang; Jianping Zhao; Gang Huang; Ziyong Sun; Wei Wang; Jianfeng Zhou
Journal:  J Mol Diagn       Date:  2020-10-26       Impact factor: 5.568

9.  Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.

Authors:  Kyoung-Ho Song; Dong-Min Kim; Hyunju Lee; Sin Young Ham; Sang-Min Oh; Hyeonju Jeong; Jongtak Jung; Chang Kyung Kang; Ji Young Park; Yu Min Kang; Ji-Yeon Kim; Jeong Su Park; Kyoung Un Park; Eu Suk Kim; Hong Bin Kim
Journal:  Korean J Intern Med       Date:  2020-11-25       Impact factor: 2.884

10.  Consecutive false-negative rRT-PCR test results for SARS-CoV-2 in patients after clinical recovery from COVID-19.

Authors:  Guan Wang; Na Yu; Weimin Xiao; Chen Zhao; Zhenning Wang
Journal:  J Med Virol       Date:  2020-07-06       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.